In particular, our results show that the combinatorial use of existing kinase inhibitors with an inhibitory effect on TNIK kinase activity and TNIK inhibitors may be an effective therapeutic strategy for the treatment of MM. The gene discussed is TNIK; the disease is Miyoshi myopathy.